Drug profile · INN
dapagliflozin propylene glycolate hydrate
FORXIGA INITIAL APPROVAL
- Patents linked
- 0
- News articles
- 0
Quick answer
dapagliflozin propylene glycolate hydrate (FORXIGA INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN dapagliflozin propylene glycolate hydrate
Brand FORXIGA INITIAL APPROVAL
Frequently asked questions
What is dapagliflozin propylene glycolate hydrate?
dapagliflozin propylene glycolate hydrate (FORXIGA INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for dapagliflozin propylene glycolate hydrate?
FORXIGA INITIAL APPROVAL is a marketed brand name for dapagliflozin propylene glycolate hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.